English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [913]
News [2608]
Articles [111]
Editorials [3]
Conferences [85]
elearning [27]
Pseudogenes may provide clearer understanding of biomarkers
Pseudogenes may provide clearer understanding of biomarkers
HIV-infected people with early-stage cancers are up to four times more likely to go untreated for cancer
HIV-infected people with early-stage cancers are up to four times more likely to go untreated for cancer
Stronger nicotine dependency associated with higher risk of lung cancer
Stronger nicotine dependency associated with higher risk of lung cancer
Lung-MAP trial launches using genomic profiling and targeting in advanced squamous cell lung cancer
Lung-MAP trial launches using genomic profiling and targeting in advanced squamous cell lung cancer
Scientists engineer nanoparticles to prevent bone cancer
Scientists engineer nanoparticles to prevent bone cancer
Study investigates online information available to lung cancer patients - invitation to take part
Study investigates online information available to lung cancer patients - invitation to take part
Investing in cancer research boosts economy as well as health
Investing in cancer research boosts economy as well as health
Survey sheds light on common clinical practice for incompletely resected lung cancer
Survey sheds light on common clinical practice for incompletely resected lung cancer
ASCO 2014: PD-1 targeting immunotherapy MK-3475 has high and long-lasting activity against metastatic melanoma
ASCO 2014: PD-1 targeting immunotherapy MK-3475 has high and long-lasting activity against metastatic melanoma
ASCO 2014: Second-line treatment with ramucirumab plus docetaxel extends survival in advanced NSCLC
ASCO 2014: Second-line treatment with ramucirumab plus docetaxel extends survival in advanced NSCLC
<1...197198199200201...261>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top